Over the past decade, three-dimensional (3D) cancer models have emerged as crucial tools in high-throughput screening (HTS), providing a more reliable bridge between in vitro and in vivo drug testing. These models demonstrate higher predictive accuracy compared to traditional two-dimensional (2D) cultures, although the lack of reproducibility and standardization is the main challenge for their translation into quantitative disease modeling and therapeutic response. Therefore, optimization and standardization of 3D spheroid cultivation protocols for HTS for various cancer cell types remain pertinent. This study establishes optimized protocols for cultivating four cancer cell lines (HCT116, SW620, PANC-1, and BxPc-3) as 3D spheroids for drug screening applications. Through systematic parameter optimization, we determined optimal seeding densities (500–1000 cells/well), formation times (3 days), and incubation periods (7–21 days) for each cell line. The application of both IC50 and score metrics allowed for a comprehensive assessment of drug efficacy, overcoming limitations associated with standard sigmoidal dose–response analysis. Testing a library of more than 100 potential CDK inhibitors identified five CDK7 inhibitors and one CDK8 inhibitor with nanomolar potency, with colorectal cancer spheroids showing approximately 10% greater sensitivity than pancreatic cancer spheroids in the cases of iCDK7_4 and iCDK7_5. This standardized approach improves reproducibility in 3D cancer model screening, potentially accelerating the preclinical evaluation of novel anticancer agents against these challenging malignancies.
Polyplex-based gene delivery systems are promising substitutes for viral vectors because of their high versatility and lack of disadvantages commonly encountered with viruses. In this work, we studied the DNA polyplexes with N-[4-(N,N,N-trimethylammonium)benzyl]chitosan chloride (TMAB-CS) of various compositions in different cell types. Investigations of the interaction of TMAB-CS with DNA by different physical methods revealed that the molecular weight and the degree of substitution do not dramatically influence the hydrodynamic properties of polyplexes. Highly substituted TMAB-CS samples had a high affinity for DNA. The transfection protocol was optimized in HEK293T cells and achieved the highest efficiency of 30–35%. TMAB-CS was dramatically less effective in nonadherent K562 cells (around 1% transfected cells), but it was more effective and less toxic than polyarginine.
Cell Painting is a high-content imaging approach that enables systematic characterization of cellular responses to chemical perturbations through quantitative morphological profiling. Although this methodology has been widely applied in drug discovery and functional genomics, ovarian cancer models remain comparatively underrepresented in Cell Painting studies. In the present work, we established a Cell Painting workflow for OVCAR-3 ovarian cancer cells and applied it to the phenotypic profiling of 54 anticancer compounds representing diverse mechanisms of action. Cells were exposed to compounds under short- and prolonged-treatment conditions, followed by multiplex fluorescent staining, high-content imaging, feature extraction using CellProfiler, and computational analysis of the resulting morphological profiles. Profiles obtained at the two treatment durations were analyzed separately. For each compound, the treatment condition showing greater within-compound consistency in PCA space was additionally retained to construct a combined dataset. Morphological relationships were explored using Pearson correlation analysis, dimensionality reduction, and unsupervised clustering. Morphological profiles showed reproducible relationships among compounds. Compounds with related mechanisms showed greater morphological similarity than expected by chance, although substantial within-class heterogeneity remained. Statistically significant cluster enrichment was observed for microtubule-targeting agents and topoisomerase inhibitors, whereas other mechanism-related patterns were incomplete. Among the evaluated clustering approaches, Leiden and agglomerative clustering produced similar separation of the Combined dataset, with silhouette scores of 0.486 and 0.482, respectively. Cell Painting identified mechanism-associated but heterogeneous morphological responses in OVCAR-3 cells. The results support the use of this model for exploratory phenotypic profiling while highlighting the influence of exposure conditions and the limited ability of morphology alone to recover annotated molecular mechanisms.
This paper addresses the problem of drugs for the treatment of iron deficiency anemia (IDA). Iron deficiency anemia is a clinical and hematological syndrome based on a violation of hemoglobin synthesis resulting from iron deficiency. Clinically, IDA is manifested by symptoms of anemia and sideropenia. The aim of the study is to develop new drugs for the treatment of IDA based on lipophilic iron compounds with oleic acid in the form of a microemulsion. Analogues of the developed compounds are presented on the pharmaceutical market, being registered exclusively as biologically active food additives (Lipofer, Sideral Forte). During the study, the following materials and methods were used: iron (III) oleate with an iron ion concentration of 25 mg/g was obtained by mixing 1.1 g (0.03 mol) of iron nitrate with 6.0 g (0.21 mol) of oleic acids. After that, the mixture was heated to 90℃ for 24 hours under constant stirring. To 3 g of the previously obtained iron (III) oleate solution, 0.56 g of ascorbyl palmitate was added in an equimolar ratio to the iron ion. The mixture was stirred for 24 hours at 90℃. The resulting iron (II) oleate emulsion showed the presence of divalent ions at a concentration of 4.77 mg/g. The total concentration of iron ions in the analyzed oleates of both types was the same. Recalculation for the initial solution in oleic acid showed that the concentration was close to the expected values. Solutions for quantifying the concentrations of the active substances of the drugs under development have been presented. The fundamental possibility of carrying out the in situ reduction of the iron ion in oleic acid using a lipophilic reducing agent, ascorbyl palmitate, has been demonstrated.
Background: Three-dimensional (3D) cancer models are currently essential tools in high-throughput screening (HTS), serving as a bridge between in vitro and in vivo approaches during drug development. Even though spheroids offer many advantages over 2D cultures, analyzing 3D cultures with heterogeneous morphology remains challenging due to the lack of standardized visualization techniques and multiparameter analysis. Methods: In this work, an optimized CellProfiler pipeline and a Python algorithm for weighting morphological features are used to visualize, extract, and analyze morphological data from spheroids derived from colorectal and pancreatic cancer cell lines with diverse morphologies (HCT116, LoVo, PANC-1, and CFPAC-1). Results: We developed a feature weighting process that combines multiple morphological parameters into a single metric using principal component analysis (PCA). There is a strong correlation between this process and a standard Alamar Blue proliferation assay (r = 0.89, ρ = 0.91, p < 0.001). Using this method, we were able to ascertain the IC50 values of substances that did not produce results in cell lines with heterogeneous morphology (LoVo and CFPAC-1) using a standard proliferation assay. Conclusions: By removing the need for tracer dyes, the resulting methodology may lower costs while accelerating preclinical drug development through informative multiparameter analysis of compound efficacy.
Three-dimensional (3D) spheroid models are increasingly used in cancer research because they reproduce several features of solid tumors that are not represented in conventional two-dimensional (2D) monolayer cultures. In the present study, we developed and optimized spheroid culture conditions for a panel of breast, ovarian, and gastric cancer cell lines grown on low-attachment plates. Spheroid formation, morphology, and growth behavior were assessed during culture, and the resulting models were used for the comparative testing of reference anticancer agents. The established assay framework was further applied to newly developed cyclin-dependent kinase 7 (CDK7) inhibitor candidates from our in-house compound library. Anticancer activity was evaluated by using AlamarBlue or PrestoBlue viability assays after prolonged drug exposure. Reproducible spheroid formation conditions were identified for the studied cell lines, although notable cell line-specific differences in morphology, growth behavior, and assay duration were observed. Comparative drug testing revealed differences in apparent sensitivity between 2D and 3D cultures depending on the cell line and compound. Several tested CDK7 inhibitor candidates reduced viability in the spheroid models, with iCDK7_1 showing the strongest activity across the evaluated panel. Overall, the study describes and applies a cell line-adapted 3D spheroid assay workflow for comparative evaluation of antiproliferative effects in breast, ovarian, and gastric cancer models.